Description: Pfizer has made more than its share of value-destroying acquisitions. The pharmaceutical giant’s $15.2 billion purchase of Hospira could reverse that history.
Source: NYTimes.com
Date: Feb 05, 2015
Questions for discussion:
- Summarize Pfizer’s M&A history.
- What’s different this time?
- Would you be an investor today?
Leave a Reply